BCL2L1 and hepatocellular carcinoma: Simultaneous treatment with Sora and Cur also increased the expression of cleaved caspase-3, cleaved caspase-9, and Bcl-xL in the HepG2 and Hep3b hepatocellular cancer cell lines [34].